• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Innovation leadership with AMARIS features SmartPulse Technology and TransPRK

Article

Bruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation, their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK.

Bruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation,  their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK. 

Back to Eye-to-Eye Innovation Series

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.